Centrum Medyczne ENEL-MED Statistics

Total Valuation

FRA:E19 has a market cap or net worth of EUR 122.32 million. The enterprise value is 187.50 million.

Market Cap	122.32M
Enterprise Value	187.50M

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	28.28M
Shares Outstanding	n/a
Shares Change (YoY)	+0.29%
Shares Change (QoQ)	-4.77%
Owned by Insiders (%)	51.65%
Owned by Institutions (%)	42.35%
Float	13.67M

Valuation Ratios

The trailing PE ratio is 50.17.

PE Ratio	50.17
Forward PE	n/a
PS Ratio	0.64
PB Ratio	2.84
P/TBV Ratio	3.19
P/FCF Ratio	9.94
P/OCF Ratio	4.87
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.38, with an EV/FCF ratio of 15.23.

EV / Earnings	76.91
EV / Sales	0.97
EV / EBITDA	12.38
EV / EBIT	40.98
EV / FCF	15.23

Financial Position

The company has a current ratio of 0.59, with a Debt / Equity ratio of 1.69.

Current Ratio	0.59
Quick Ratio	0.56
Debt / Equity	1.69
Debt / EBITDA	4.84
Debt / FCF	5.90
Interest Coverage	1.70

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	4.39%
Revenue Per Employee	160,257
Profits Per Employee	2,032
Employee Count	1,200
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:E19 has paid 699,079 in taxes.

Income Tax	699,079
Effective Tax Rate	22.28%

Stock Price Statistics

The stock price has decreased by -10.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.86%
50-Day Moving Average	4.05
200-Day Moving Average	4.27
Relative Strength Index (RSI)	45.26
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:E19 had revenue of EUR 192.31 million and earned 2.44 million in profits. Earnings per share was 0.09.

Revenue	192.31M
Gross Profit	17.45M
Operating Income	4.54M
Pretax Income	3.14M
Net Income	2.44M
EBITDA	4.02M
EBIT	4.54M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 8.03 million in cash and 72.66 million in debt, giving a net cash position of -64.63 million.

Cash & Cash Equivalents	8.03M
Total Debt	72.66M
Net Cash	-64.63M
Net Cash Per Share	n/a
Equity (Book Value)	43.03M
Book Value Per Share	1.52
Working Capital	-14.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.12 million and capital expenditures -12.80 million, giving a free cash flow of 12.31 million.

Operating Cash Flow	25.12M
Capital Expenditures	-12.80M
Free Cash Flow	12.31M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 9.07%, with operating and profit margins of 2.36% and 1.27%.

Gross Margin	9.07%
Operating Margin	2.36%
Pretax Margin	1.63%
Profit Margin	1.27%
EBITDA Margin	2.09%
EBIT Margin	2.36%
FCF Margin	6.40%

Dividends & Yields

FRA:E19 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.29%
Shareholder Yield	-0.29%
Earnings Yield	1.99%
FCF Yield	10.06%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:E19 has an Altman Z-Score of 2.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.33
Piotroski F-Score	4